Delayed
OTC Markets
10:59:36 2024-05-07 am EDT
5-day change
1st Jan Change
0.002
USD
0.00%
0.00%
-20.00%
This article is reserved for members
Not a member ?
Free registration
Han Kieftenbeld to leave as Chief Financial Officer of Amyris, Inc
May. 07
CI
Kathy L. Fortmann to Join Amyris, Inc. as Member of the Board of Directors
May. 07
CI
Amyris, Inc. Announces Chief Executive Officer Changes
May. 07
CI
Amyris, Inc. Emerged from Bankruptcy
May. 07
CI
North American Morning Briefing : Stock Futures -2-
Mar. 13
DJ
Third Amended Joint Reorganization Plan Filed by Amyris, Inc.
Jan. 22
CI
Notice for Auction Cancellation Filed by Amyris, Inc.
Jan. 16
CI
Foris Ventures Provides Information to the Shareholders
Jan. 05
CI
Advance Auto Parts Names Elizabeth Dreyer as Chief Accounting Officer
Jan. 05
MT
First Motion for Exclusivity Period Extension Approved For Amyris, Inc.
Jan. 04
CI
Amyris, Inc., Amyris Clean Beauty, Inc., and Aprinnova, LLC Enter into Amendment to That Certain Senior Secured Super Priority Debtor in Possession Loan Agreement
Jan. 04
CI
Motion for Asset Sale Approved for Amyris, Inc.
Jan. 03
CI
Dr. Reddy's Laboratories Acquires MenoLabs Business
Jan. 03
MT
Mounting Geopolitical Tensions Weigh Down Indian Equities on Wednesday
Jan. 03
MT
Dr. Reddy's Acquires Women's Health and Diery Supplements Brand MenoLabs
Jan. 03
MT
Amyris, Inc. cancelled the transaction announced on December 29, 2022
Dec. 28
CI
Amyris, Inc. Announces Resignation of Elizabeth Dreyer as Chief Accounting Officer and Corporate Controller, Effective as of January 2, 2024
Dec. 27
CI
Motion for Asset Sale Approved for Amyris, Inc.
Dec. 20
CI
Motion for Asset Sale Approved for Amyris, Inc.
Dec. 20
CI
Motion for Asset Sale Approved for Amyris, Inc.
Dec. 20
CI
Bidding Procedure Approved for Amyris, Inc.
Dec. 19
CI
Motion for Asset Sale Filed by Amyris, Inc.
Dec. 14
CI
Notice of Selection of Successful Bidder by Amyris, Inc.
Dec. 13
CI
Motion for Asset Sale Approved for Amyris, Inc.
Dec. 11
CI
Motion for Asset Sale Approved for Amyris, Inc.
Dec. 11
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Companyâs sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
More about the company
1st Jan change
Capi.
+17.44% 66.52B +3.11% 50.34B +17.62% 42.01B +20.88% 26.68B +12.26% 19.97B +2.07% 17.32B -23.54% 15.7B +0.96% 15.53B -11.70% 14.99B
Other Specialty Chemicals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
#252525**/registration/member/**Blanc**1**7**To continue browsing, please register!**#ffffff50**14px**#33d251**